Pankaj Mohan is CEO & Chairman +1 at Sonnet BioTherapeutics Holdings, Inc. (SONN). They have made 7 open-market trades across 3 companies since 2017, most recently 2023-12-11.
CIK 0001664386
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $182K since 2019, against 2 sales. Across 5 scored buys the stock is down 18.7% at ninety days, and 28.3 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 40% | 40% |
| Avg Move | +8.8% | +45.6% | -18.7% |
| Alpha | +8.1% | +40.6% | -28.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SONN | BUY | 2023-05-15 | 2023-05-15 | $0.22 | $82K | +70.2% | +210.3% | +44.7% |
| SONN | BUY | 2023-03-15 | 2023-03-16 | $0.59 | $35K | -39.7% | -37.6% | +25.7% |
| SONN | BUY | 2021-06-09 | 2021-06-09 | $1.55 | $50K | -6.8% | -18.6% | -60.9% |
| SONN | BUY | 2020-06-10 | 2020-06-12 | $4.09 | $10K | +18.7% | -12.2% | -31.2% |
| OTLK | BUY | 2019-01-15 | 2019-01-17 | $0.68 | $5K | +1.8% | +85.9% | -72.0% |
| ONS | SELL | 2018-01-03 | 2018-01-05 | $1.17 | $268K | -2.1% | -3.3% | -21.7% |
| ONS | SELL | 2017-12-18 | 2017-12-20 | $1.14 | $215K | -4.9% | -5.7% | -24.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.